INDEPENDENT THINKING. WHOLE-FOOD LIVING.NO ANIMALS / NO OIL
THENANODIET
← THE STUDY LIBRARY

Systematic review / meta-analysis / 2019

Higher circulating TMAO levels were associated with an increased risk of diabetes.

In a meta-analysis of 12 clinical studies encompassing 15,314 participants, elevated circulating TMAO levels were linked to higher odds of diabetes (OR = 1.89). Individuals with diabetes exhibited higher plasma TMAO concentrations than those without (SMD: 0.36). In dose-response evaluation, every 5 μmol/L rise in plasma TMAO was associated with a 54% greater risk of diabetes (OR = 1.54).

Study type
Systematic review and dose-response meta-analysis
Who was studied
15,314 participants across 12 clinical studies
What was measured
diabetes risk and plasma TMAO levels

THE PAPER

Gut microbe-generated metabolite trimethylamine N-oxide and the risk of diabetes: A systematic review and dose-response meta-analysis.

Zhuang R, Ge X, Han L, Yu P, Gong X, Meng Q, Zhang Y, Fan H, Zheng L, Liu Z, Zhou X. Obes Rev, 2019.

PubMed 30868721 ↗DOI 10.1111/obr.12843 ↗

Diabetes & blood sugarGut & microbiome

This note is written from the study's published abstract. It summarizes what the authors reported; it is not medical advice and does not replace reading the full paper.